A Comparison of the Glaucoma Probability Score to Earlier Heidelberg Retina Tomograph Data Analysis Tools in Classifying Normal and Glaucoma Patients

Article

A Comparison of the Glaucoma Probability Score to Earlier Heidelberg Retina Tomograph Data Analysis Tools in Classifying Normal and Glaucoma Patients

Please click here to read the full story.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Modern monitoring strategies remove major barriers to retina care
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Tyson Brunstetter, OD, PhD, shares key takeaways from his keynote at the International SPECTRALIS Symposium
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
The cornea is the unsung hero of diagnosing neurodegeneration, says Rayaz Malik, MBChB, PhD
EYLEA 8mg in focus: Key learnings from the pivotal trials
EYLEA 8mg in focus: Key learnings from the pivotal trials
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
Early intervention is crucial for long-term outcomes in paediatric gene therapy
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Robert Ang, MD, explains why a small-aperture IOL is "not a niche product"
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
ARVO 2025: Anat Loewenstein, MD, and colleagues on meeting needs of patients with diabetic retinopathy
Related Content
Concept image for telehealth, telemedicine, remote ophthalmology, retinal imaging and monitoring, hospital health system and community care collaboration. Image credit: ©Melinda Nagy – stock.adobe.com

How remote retinal imaging raises the bar across service, research and education

Hattie Hayes;Baljean Dhillon, FRCPS, FRCS, FRCOphth, FRCPE
June 14th 2025
Article

Prof Baljean Dhillon advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

Scientists work in a lab, looking at microscopes while data is superimposed over the top of the photo. Concept image for clinical trial research and structural functional endpoints in ophthalmology. Image credit: ©metamorworks – stock.adobe.com

Imaging the ellipsoid zone line could change the global approach to clinical trials

Hattie Hayes;Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS
June 13th 2025
Article

Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS, presented two studies involving the EZ line at this year’s International SPECTRALIS Symposium

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Gereon Hüttmann, PhD, deputy head of the Institute of Biomedical Optics, University of Lübeck, Germany, presented on holographic optical coherence tomography (HOLO-OCT) at the International SPECTRALIS Symposium (ISS)

Gereon Hüttmann, PhD, introduces holographic OCT to a new audience

Hattie Hayes;Gereon Hüttmann, PhD
June 13th 2025
Article

The new technology will be crucial to imaging retinal function in the future, Prof Hüttmann predicted at the International SPECTRALIS Symposium

An elderly man and woman walk down a path in a sunny park with grass and trees. Concept image for NICOLA, The Northern Ireland Cohort for the Longitudinal Study of Ageing. Image credit: ©Ivica Drusany – stock.adobe.com

Ruth Hogg, PhD, says NICOLA data emphasise the value of multicolor images

Hattie Hayes;Ruth Hogg, PhD
June 13th 2025
Article

Prof Hogg presented a wide breadth of research at the International SPECTRALIS Symposium

© 2025 MJH Life Sciences

All rights reserved.